Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Expected outcome: unpredictable, possible product contamination
This specific property has become the focus of numerous research strategies, such as the development of senolytic agents like FOXO4-DRI, which selectively disrupt the FOXO4p53 interaction, thereby enabling the targeted elimination of dysfunctional cells
The evidence is mixed
Aliquot the stock solution into single-use volumes in low-protein-binding microcentrifuge tubes (1.5 mL format), label with compound name, concentration, date of reconstitution, and your initials
US$ 27.93
US$ 27.04
US$ 26.95
